Mothers, we need your help! Mothers, we need your help!

The drug that we will use to prevent FNAIT can only be made from blood from women who have previously given birth to an FNAIT child.

Please sign up as plasma donor, if you have given birth to an FNAIT child and want to help us save the lives of babies at risk of developing FNAIT.

The drug that we will use to prevent FNAIT can only be made from blood from women who have previously given birth to an FNAIT child.

Please sign up as plasma donor, if you have given birth to an FNAIT child and want to help us save the lives of babies at risk of developing FNAIT.
Sign up
Video
Prophylix Pharma

is aiming to develop a safe new treatment that prevents excessive bleeding in fetuses and newborns caused by FNAIT. Today, such bleedings may cause life-long disabilities or death.

Read more
FNAIT

Some excessive bleedings in foetuses and neonates occur because there are too few platelets to stop the bleeding. This may be caused by Foetal Neonatal Alloimmune Thrombocytopenia (FNAIT).

Read more
The PROFNAIT project

is an EU-funded collaboration between Prophylix Pharma, Biotest AG, Larix A/S and leading hospitals, blood banks and universities in Europe aimed at developing a prophylaxis against FNAIT.

Read more